Modi Ventures proudly announces a successful funding round that raised $88,000,000, marking a significant milestone in our journey of blending innovative technology with transformative biology and medicine. As a private fund at the cutting edge, we specialize in identifying and nurturing ventures that blend advanced artificial intelligence with next-generation medical technologies, reshaping the future of humanity. This fresh infusion of capital will empower us to further our mission by expanding our strategic investments in both early-stage startups and high-potential venture capital funds. Our extensive network includes remarkable partners like Khosla Ventures, Section 32, Abingworth, Draper Associates, Artis Ventures, among others, as well as a dynamic portfolio of startups such as Generate Biomedicines, Atomic AI, Lapsi Health, Harbinger Health, Latus Bio, and Ozlo Sleep.
The new funds will be channeled toward accelerating breakthrough research and development, expanding our global footprint, and deepening our commitment to discovering and supporting cutting-edge technologies. By strategically deploying this capital, we aim to fuel innovation that has the potential to improve healthcare and enhance lives on a global scale. This funding round not only reinforces the confidence that esteemed investors have in our vision but also solidifies our position as a catalyst for transformative change at the intersection of technology and medicine. As we forge ahead into the future, Modi Ventures remains dedicated to empowering visionary entrepreneurs and trailblazing companies that are reshaping the landscape of healthcare and technology innovation.
